SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-001161
Filing Date
2017-01-26
Accepted
2017-01-26 18:35:41
Documents
1
Period of Report
2017-01-25

Document Format Files

Seq Description Document Type Size
1 SIECZKAREK rdgdoc.html 4  
1 SIECZKAREK rdgdoc.xml 4 4293
  Complete submission text file 0001437749-17-001161.txt   5526
Mailing Address
Business Address
SIECZKAREK MARK M (Reporting) CIK: 0001188738 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 17551249

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations